Seattle, WA, January 24, 2014 –– Deborah Gates recently
collaborated on the production of a new review video about the Lilash eyelash growth product.
"Eyelash enhancing products are
extremely popular today and the market is flooded with numerous products which
aim to give eyelashes a longer appearance. So when a product like Lilash comes
out that claims to be able to grow the length of the lashes then this grabs a
lot of attention" explains Deborah, a Seattle based beauty and fashion
expert.
Deborah goes on to say that many
women yearn for longer lashes and so for a product to be able to give them the
lushes lashes that they have always desired would be something welcomed by
almost all women, so clearly there would be a huge market for legitimate
eyelash growth products.
Lilash is a topical eyelash serum
containing, according to the manufacturer, natural botanicals which help to
strengthen and lengthen the lashes. However, there are some reservations when
it comes to products like this, especially in light of the kind of side effects
that are possible when using a similar product known as Latisse, which is a
prescription-only eyelash growth product on the market. However, according to
the manufacturers of Lilash, the only possible side effects are mild skin
irritation.
To apply the Lilash serum you simply
use the applicator to apply the liquid to the skin of the eyelid, but not the
lower lashes themselves. You need to use it once a day for roughly two to three
months, and then just twice a week as maintenance. According to the
manufacturer, one tube of Lilash should last up to six months with proper
usage.
According to Deborah: "The Lilash reviews video we created details what you can realistically
expect to achieve while using the product. While many users of Latisse have
reported some change in eye color while using the product, so far this is yet
to be the case with Lilash users."
If you would like to find out more
about Lilash then feel free to refer to the link below: http://www.youtube.com/channel/UCVduGr2Tma1CKNNUFoMXyzw
No comments:
Post a Comment